Adult stem cell differentiation and trafficking and their implications in disease

Advances in Experimental Medicine and Biology

Volumn 695, Issue , 2010, Pages 169-183

  Zhuge, Ying ^b   Liu, Zhao Jun ^b   Velazquez, Omaida C ^a  

^a Division of Vascular and Endovascular Surgery   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CHEMOKINE RECEPTOR CXCR4; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; MIXED LINEAGE LEUKEMIA PROTEIN; PLATELET DERIVED GROWTH FACTOR B; SPHINGOSINE 1 PHOSPHATE; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR TAL1;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL RENEWAL; CHONDROGENESIS; CYTOSKELETON; DOWN REGULATION; EFFECTOR CELL; ENDOTHELIAL PROGENITOR CELL; ERYTHROCYTE; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; LEUKOCYTE; MESENCHYMAL STEM CELL; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR REPROGRAMMING; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STEM CELL; STROMA CELL; BONE MARROW CELL; CELL MOTION; CYTOLOGY; MESENCHYMAL STROMA CELL;

BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 79954568483     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7037-4_12     Document Type: Article

References (101)

1. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007: 58:267-84. (Pubitemid 46706514)
2. Laird DJ, von Andrian UH, Wagers AJ. Stem cell trafficking in tissue development, growth and disease. Cell 2008: 132(4):612-30. (Pubitemid 351253693)
3. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008: 132(4):631-44. (Pubitemid 351260057)
4. Orkin SH. Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet 2000: 1(1):57-64.
5. Kim SI, Bresnick EH. Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene 2007: 26(47):6777-94. (Pubitemid 47585102)
6. Mikkola HK, Klintman J, Yang H et al. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 2003: 421(6922):547-51. (Pubitemid 36168449)
7. Ichikawa M, Asai T, Saito T et al. AML-1 is required for megakaryocyte maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 2004: 10(3):299-304. (Pubitemid 38667622)
8. Kulessa H, Frampton J, Graf T. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts and erythroblasts. Genes Dev 1995: 9(10):1250-62.
9. Nerlov C, Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev 1998: 12(15):2403-12. (Pubitemid 28371359)
10. Nutt SL, Heavey B, Rolink AG et al. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999: 401(6753):556-62.
11. McDevitt MA, Shivdasani RA, Fujiwara Y et al. A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci USA 1997: 94(13):6781-5.
12. Orkin SH. Priming the hematopoietic pump. Immunity 2003: 19(5):633-4. (Pubitemid 37490786)
13. Chen H, Ray-Gallet D, Zhang P et al. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 1995: 11(8):1549-60.
14. Tsai SF, Strauss E, Orkin SH. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev 1991: 5(6):919-31. (Pubitemid 21906007)
15. Iwasaki H, Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007: 26(6):726-40. (Pubitemid 46907674)
16. Laiosa CV, Stadtfeld M, Xie H et al. Reprogramming of committed T-cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity 2006: 25(5):731-44. (Pubitemid 46107288)
17. Xie H, Ye M, Feng R et al. Stepwise reprogramming of B cells into macrophages. Cell 2004: 117(5):663-76. (Pubitemid 38692531)
18. Busslinger M, Nutt SL, Rolink AG. Lineage commitment in lymphopoiesis. Curr Opin Immunol 2000: 12(2):151-8. (Pubitemid 30133102)
19. Zhang P, Zhang X, Iwama A et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 2000: 96(8):2641-8.
20. Nerlov C, Querfurth E, Kulessa H et al. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 2000: 95(8):2543-51. (Pubitemid 30210532)
21. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T-cells. Cell 1997: 89(4):587-96. (Pubitemid 27511769)
22. Szabo SJ, Kim ST, Costa GL et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000: 100(6):655-69.
23. Wechsler J, Greene M, McDevitt MA et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002; 32(1):148-52. (Pubitemid 34977210)
24. Mueller BU, Pabst T, Osato M et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 2002;100(3):998-1007. (Pubitemid 34832629)
25. Pabst T, Mueller BU, Zhang P et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001; 27(3):263-70. (Pubitemid 32201846)
26. Mullighan CG, Goorha S, Radtke I et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446(7137):758-64. (Pubitemid 46582031)
27. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 2009;106(6):984-91.
28. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for definingmultipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4):315-7. (Pubitemid 44269669)
29. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts and assays. Cell Stem Cell 2008; 2(4):313-9. (Pubitemid 351467394)
30. Chen FH, Rousche KT, Tuan RS. Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2006; 2(7):373-82.
31. Mimeault M, Batra SK. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer. Gut 2008; 57(10):1456-68.
32. Baksh D, Tuan RS. Canonical and noncanonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol 2007; 212(3):817-26. (Pubitemid 47267551)
33. Barry F, Boynton RE, Liu B et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 2001; 268(2):189-200. (Pubitemid 32744650)
34. Ito T, Sawada R, Fujiwara Y et al. FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling. Cytotechnology 2008; 56(1):1-7.
35. Kratchmarova I, Blagoev B, Haack-Sorensen M et al. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005; 308(5727):1472-7. (Pubitemid 40791302)
36. Matsuda C, Takagi M, Hattori T et al. Differentiation of Human Bone Marrow Mesenchymal Stem Cells to Chondrocytes for Construction of Three-dimensional Cartilage Tissue. Cytotechnology 2005; 47(1-3):11-7. (Pubitemid 41784661)
37. Nedeau AE, Bauer RJ, Gallagher K et al. A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res 2008; 314(11-12):2176-86. (Pubitemid 351822331)
38. Tsuchiya H, Kitoh H, Sugiura F et al. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 2003; 301(2):338-43. (Pubitemid 36279243)
39. Hristov M, Weber C. Progenitor cell trafficking in the vascular wall. J Thromb Haemost 2009; 7 Suppl 1:31-4.
40. Zhang D, Fan GC, Zhou X et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 2008; 44(2):281-92.
41. Haider H, Jiang S, Idris NM et al. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 2008; 103(11):1300-8.
42. Chavakis E, Hain A, Vinci M et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007; 100(2):204-12. (Pubitemid 46208720)
43. Palumbo R, Bianchi ME. High mobility group box 1 protein, a cue for stem cell recruitment. Biochem Pharmacol 2004; 68(6):1165-70. (Pubitemid 39094282)
44. Ley K, Laudanna C, Cybulsky MI et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7(9):678-89. (Pubitemid 47327397)
45. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005; 6(12):1182-90. (Pubitemid 43045626)
46. Ruster B, Gottig S, Ludwig RJ et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006; 108(12):3938-44. (Pubitemid 44864580)
47. Krampera M, Pizzolo G, Aprili G et al. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 2006; 39(4):678-83. (Pubitemid 44311724)
48. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226(6):507-20. (Pubitemid 32524497)
49. Sackstein R, Merzaban JS, Cain DW et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 2008; 14(2):181-7. (Pubitemid 351214550)
50. Timmermans F, Van Hauwermeiren F, De Smedt M et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007: 27(7):1572-9. (Pubitemid 46986112)
51. Gallagher KA, Liu ZJ, Xiao M et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007: 117(5):1249-59. (Pubitemid 46718413)
52. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007: 28(7):299-307. (Pubitemid 46963141)
53. Ceradini DJ, Kulkarni AR, Callaghan MJ et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004: 10(8):858-64. (Pubitemid 39070860)
54. Abbott JD, Huang Y, Liu D et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004: 110(21):3300-5. (Pubitemid 39557491)
55. Walter DH, Haendeler J, Reinhold J et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005: 97(11):1142-51.
56. Hristov M, Weber C. Ambivalence of progenitor cells in vascular repair and plaque stability. Curr Opin Lipidol 2008: 19(5):491-7.
57. Hristov M, Zernecke A, Bidzhekov K et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 2007: 100(4):590-7. (Pubitemid 46673269)
58. Hristov M, Zernecke A, Liehn EA et al. Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost 2007: 98(2):274-7. (Pubitemid 47250227)
59. George J, Afek A, Abashidze A et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005: 25(12):2636-41. (Pubitemid 43732290)
60. Broxmeyer HE, Orschell CM, Clapp DW et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005: 201(8):1307-18. (Pubitemid 40629073)
61. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002: 16(10):1992-2003. (Pubitemid 35203441)
62. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005: 15(2):57-63. (Pubitemid 40693388)
63. Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003: 9(11):1370-6. (Pubitemid 37466185)
64. Schulz C, von Andrian UH, Massberg S. Hematopoietic stem and progenitor cells: their mobilization and homing to bone marrow and peripheral tissue. Immunol Res 2009: 44(1-3):160-8.
65. Heissig B, Hattori K, Dias S et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002: 109(5):625-37. (Pubitemid 34628725)
66. Kollet O, Dar A, Shivtiel S et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006: 12(6):657-64. (Pubitemid 43865234)
67. Christopherson KW, 2nd, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 2003: 101(12):4680-6. (Pubitemid 36857720)
68. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994: 76(2):301-14. (Pubitemid 24046692)
69. Potocnik AJ, Brakebusch C, Fassler R. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen and bone marrow. Immunity 2000: 12(6):653-63.
70. Levesque JP, Takamatsu Y, Nilsson SK et al. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001: 98(5):1289-97.
71. Papayannopoulou T, Craddock C, Nakamoto B et al. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995: 92(21):9647-51.
72. Papayannopoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA 1993: 90(20):9374-8. (Pubitemid 23315786)
73. Wagers AJ, Allsopp RC, Weissman IL. Changes in integrin expression are associated with altered homing properties of Lin(-/lo)Thy1.1(lo)Sca-1(+)c-kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp Hematol 2002: 30(2):176-85. (Pubitemid 34081229)
74. Katayama Y, Hidalgo A, Furie BC et al. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood 2003: 102(6):2060-7. (Pubitemid 37122380)
75. Mazo IB, Gutierrez-Ramos JC, Frenette PS et al von Andrian UH. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 1998; 188(3):465-74. (Pubitemid 28369136)
76. Hla T, Venkataraman K, Michaud J. The vascular S1P gradient-cellular sources and biological significance. Biochim Biophys Acta 2008; 1781(9):477-82.
77. Yatomi Y, Igarashi Y, Yang L et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 1997; 121(5):969-73. (Pubitemid 27236918)
78. Pappu R, Schwab SR, Cornelissen I et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007; 316(5822):295-8. (Pubitemid 46633109)
79. Rosen H, Gonzalez-Cabrera P, Marsolais D et al. Modulating tone: the overture of S1P receptor immunotherapeutics. Immunol Rev 2008; 223:221-35. (Pubitemid 351986190)
80. Massberg S, Schaerli P, Knezevic-Maramica I et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph and peripheral tissues. Cell 2007; 131(5):994-1008. (Pubitemid 350138089)
81. Hoshino K, Takeuchi O, Kawai T et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162(7):3749-52. (Pubitemid 29314747)
82. Nagai Y, Garrett KP, Ohta S et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006; 24(6):801-12. (Pubitemid 43867369)
83. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004; 4(7):540-50. (Pubitemid 38868623)
84. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107(5):1761-7. (Pubitemid 43289351)
85. Kaplan RN, Riba RD, Zacharoulis S et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature 2005; 438(7069):820-7. (Pubitemid 41753060)
86. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97(7):3422-7. (Pubitemid 30183318)
87. Majka SM, Jackson KA, Kienstra KA et al. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 2003; 111(1):71-9. (Pubitemid 36134850)
88. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5(4):434-8. (Pubitemid 29180584)
89. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7(4):430-6. (Pubitemid 32298545)
90. Orlic D, Kajstura J, Chimenti S et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001; 938:221-9; discussion 29-30.
91. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410(6829):701-5. (Pubitemid 32290358)
92. Kaushal S, Amiel GE, Guleserian KJ et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7(9):1035-40. (Pubitemid 32937384)
93. Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92(2):362-7. (Pubitemid 28323695)
94. Sata M, Saiura A, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8(4):403-9. (Pubitemid 34407037)
95. Grant MB, May WS, Caballero S et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002; 8(6):607-12. (Pubitemid 34633439)
96. Otani A, Kinder K, Ewalt K et al. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 2002; 8(9):1004-10. (Pubitemid 35033705)
97. Young PP, Hofling AA, Sands MS. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc Natl Acad Sci USA 2002; 99(18):11951-6. (Pubitemid 34994505)
98. Lyden D, Hattori K, Dias S et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7(11):1194-201. (Pubitemid 33063774)
99. Reyes M, Dudek A, Jahagirdar B et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109(3):337-46. (Pubitemid 34141807)
100. Peled A, Petit I, Kollet O et al. Dependence of human stem cell engraftment and repopulation of NOD/ SCID mice on CXCR4. Science 1999; 283(5403):845-8.
101. Sugiyama T, Kohara H, Noda M et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006; 25(6):977-88. (Pubitemid 44894948)